Antisense Oligonucleotide Therapy for Ophthalmic Conditions
Author:
Affiliation:
1. Inherited Retinal Disorders Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States
Funder
This study was not supported by any grant or research funding
Publisher
Informa UK Limited
Subject
Ophthalmology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/08820538.2021.1914116
Reference66 articles.
1. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
2. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy
3. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.
4. FDA-Approved Oligonucleotide Therapies in 2017
5. Eteplirsen in the treatment of Duchenne muscular dystrophy
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Characteristics of Eyes With CRB1-Associated EOSRD/LCA: Age-Related Changes;American Journal of Ophthalmology;2024-07
2. Construction Strategy of Functionalized Liposomes and Multidimensional Application;Small;2024-01-22
3. Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications;Colloids and Surfaces B: Biointerfaces;2023-09
4. Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling;Allergy;2022-12-07
5. Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells;Biomedicines;2022-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3